ADMA BIOLOGICS INC (ADMA) Forecast, Price Target & Analyst Ratings

NASDAQ:ADMA • US0008991046

Current stock price

9.16 USD
+0.01 (+0.11%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADMA BIOLOGICS INC (ADMA).

Forecast Snapshot

Consensus Price Target

Price Target
$26.18
+ 185.81% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.20
Revenue Estimate
145.55M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$26.18
Upside
+ 185.81%
From current price of $9.16 to mean target of $26.18, Based on 9 analyst forecasts
Low
$17.17
Median
$30.60
High
$31.50

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for ADMA. The average price target is 26.18 USD. This implies a price increase of 185.81% is expected in the next year compared to the current price of 9.16.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ADMA Current Analyst RatingADMA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

ADMA Historical Analyst RatingsADMA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
ADMA was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ADMA.
In the previous month the buy percentage consensus was at a similar level.
ADMA was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-26Cantor FitzgeraldDowngrade Overweight -> Neutral
2025-05-08Raymond JamesMaintains Strong Buy -> Strong Buy
2025-03-04Cantor FitzgeraldReiterate Overweight -> Overweight
2024-11-08Raymond JamesMaintains Strong Buy -> Strong Buy
2024-11-08HC Wainwright & Co.Maintains Buy -> Buy
2024-10-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-20Cantor FitzgeraldReiterate Overweight -> Overweight
2024-08-12HC Wainwright & Co.Maintains Buy -> Buy
2024-08-09Cantor FitzgeraldMaintains Overweight -> Overweight
2024-07-09Cantor FitzgeraldMaintains Overweight -> Overweight
2024-06-20MizuhoMaintains Buy -> Buy
2024-05-10Cantor FitzgeraldMaintains Overweight -> Overweight
2024-05-10MizuhoMaintains Buy -> Buy
2024-05-10Raymond JamesMaintains Strong Buy -> Strong Buy
2024-05-10HC Wainwright & Co.Maintains Buy -> Buy
2024-03-26HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-01MizuhoMaintains Buy -> Buy
2024-02-29Cantor FitzgeraldMaintains Overweight -> Overweight
2024-02-29HC Wainwright & Co.Reiterate Buy -> Buy
2024-01-22MizuhoMaintains Buy -> Buy
2024-01-09HC Wainwright & Co.Maintains Buy -> Buy
2023-12-19Cantor FitzgeraldReiterate Overweight -> Overweight
2023-11-17HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-10Cantor FitzgeraldMaintains Overweight -> Overweight
2023-08-10Raymond JamesMaintains Strong Buy -> Strong Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.20
Revenue Estimate
145.55M
Revenue Q2Q
26.78%
EPS Q2Q
80.82%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.39%
Revenue (3 Months)
-1.93%
EPS (1 Month)
2.63%
EPS (3 Months)
2.63%

Next Earnings Summary

ADMA is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.2 USD and the consensus revenue estimate is 145.55M USD.
The next earnings revenue estimate has been revised downward by 1.93% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ADMA revenue by date.ADMA revenue by date.
258.215M
67.56%		426.454M
65.15%		510.173M
19.63%		650.25M
27.46%		794.02M
22.11%		963.75M
21.38%		1.152B
19.53%		1.288B
11.81%		1.205B
-6.44%		1.222B
1.41%		1.239B
1.39%
EBITDA
YoY % growth
ADMA ebitda by date.ADMA ebitda by date.
32.734M
201.69%		147.028M
349.16%		199.539M
35.71%		364.14M
82.49%		453.39M
24.51%		556.92M
22.83%		715.94M
28.55%		869.24M
21.41%		N/AN/AN/A
EBIT
YoY % growth
ADMA ebit by date.ADMA ebit by date.
24.402M
162.09%		138.983M
469.56%		191.443M
37.75%		309.57M
61.70%		407.44M
31.61%		516.94M
26.88%		640.66M
23.93%		728.33M
13.68%		636.89M
-12.55%		641.58M
0.74%		646.07M
0.70%
Operating Margin
ADMA operating margin by date.ADMA operating margin by date.
9.45%32.59%37.53%47.61%51.31%53.64%55.61%56.55%52.85%52.50%52.14%
EPS
YoY % growth
ADMA eps by date.ADMA eps by date.
-0.13
58.06%		0.50
484.62%		0.60
20.00%		0.92
53.85%		1.20
30.02%		1.60
33.00%		2.19
37.38%		2.71
23.72%		1.84
-32.33%		1.87
1.67%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.20
80.82%		0.23
63.93%		0.26
70.00%		0.29
42.80%		0.24
23.08%		0.28
20.00%		0.31
20.00%		0.37
28.57%
Revenue
Q2Q % growth		145.55M
26.78%		156.37M
28.19%		167.64M
24.90%		180.95M
30.03%		177.28M
21.80%		187.48M
19.90%		202.47M
20.78%		223.79M
23.68%
EBITDA
Q2Q % growth		78.948M
114.24%		90.576M
93.44%		98.634M
72.85%		107M
51.03%		N/AN/AN/AN/A
EBIT
Q2Q % growth		63.75M
82.76%		72.828M
70.17%		81.447M
59.66%		91.596M
45.97%		79.356M
24.48%		89.556M
22.97%		97.716M
19.97%		119.03M
29.95%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ADMA Yearly Revenue VS EstimatesADMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
ADMA Yearly EPS VS EstimatesADMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
38.57%
EPS Next 5 Year
35.23%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
22.77%
Revenue Next 5 Year
19.85%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
42.39%
EBIT Next 5 Year
35.13%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ADMA BIOLOGICS INC / ADMA Forecast FAQ

Can you provide the average price target for ADMA BIOLOGICS INC stock?

9 analysts have analysed ADMA and the average price target is 26.18 USD. This implies a price increase of 185.81% is expected in the next year compared to the current price of 9.16.

When does ADMA BIOLOGICS INC (ADMA) report earnings?

ADMA BIOLOGICS INC (ADMA) will report earnings on 2026-05-05.

What are the consensus estimates for ADMA BIOLOGICS INC (ADMA) next earnings?

The consensus EPS estimate for the next earnings of ADMA BIOLOGICS INC (ADMA) is 0.2 USD and the consensus revenue estimate is 145.55M USD.

How do analysts rate ADMA BIOLOGICS INC (ADMA)?

The consensus rating for ADMA BIOLOGICS INC (ADMA) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.